---
title: "Barinthus Biotherapeutics (BRNS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/BRNS.US/norm.md"
symbol: "BRNS.US"
name: "Barinthus Biotherapeutics"
parent: "https://longbridge.com/zh-CN/quote/BRNS.US.md"
datetime: "2026-05-21T06:28:32.027Z"
locales:
  - [en](https://longbridge.com/en/quote/BRNS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BRNS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BRNS.US/norm.md)
---

# Barinthus Biotherapeutics (BRNS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1400 | -0.2716 | -0.3600 | -0.5236 | -0.4900 |
| ROE | -31.47% | -55.91% | -62.37% | -77.56% | -64.02% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -5.53M | -11.09M | -14.57M | -21.12M | -19.65M |
| 营业利润 | -5.93M | -4.88M | -10.23M | -21.98M | -20.60M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 92.14M | 98.17M | 109.20M | 129.56M | 142.00M |
| 权益乘数 | 1.39 | 1.32 | 1.29 | 1.26 | 1.23 |
| 每股净资产 | 1.63 | 1.82 | 2.07 | 2.54 | 2.86 |
| 资产周转率 | - | - | 0.0000 | 0.0946 | 0.0877 |
| 现金及短投 | 65.86M | 70.46M | 74.27M | 86.26M | 99.12M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 4.90M | 5.16M | 6.58M | 7.84M | 10.06M |
| 净债务 | -54.85M | -59.17M | -62.70M | -74.27M | -87.20M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | -4.24M | -10.73M | -18.11M | -14.90M |
| 投资现金流 | - | 2000.00 | 451000.00 | -32000.00 | -5000.00 |
| 融资现金流 | - | 0.0000 | 0.0000 | 0.0000 | 2000.00 |
| 自由现金流 | - | 2.94M | -6.17M | -14.77M | -9.78M |
| 现金流充裕率 | - | - | - | -56590.63% | -298040.00% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 0.0000 | 0.0000 | -32000.00 | -5000.00 |